EUVIMEDEUVIMED entdecken
Open Access

CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition

Dong Jiang, Zhi Qi, Zhiying Xu, Yiran Li

Oncology Research · 2025

DOI: 10.32604/or.2024.050125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Dong Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Epithelial-Mesenchymal Transition, Liver Neoplasms, Transforming Growth Factor beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularEpithelial-Mesenchymal TransitionLiver NeoplasmsTransforming Growth Factor betaHumansAnimalsMicePrognosisCell ProliferationGene Expression Regulation, NeoplasticCell MovementDisease ProgressionCell Line, TumorMice, NudeBiomarkers, TumorXenograft Model Antitumor AssaysFemaleMale

Stichwörter der Autor:innen

Cytochrome b5 domain containing 2 (CYB5D2)Epithelial-mesenchymal transition (EMT)Hepatocellular carcinoma (HCC)Malignant progressionTransforming growth factor beta (TGF-β)

Substanzen

Transforming Growth Factor betaBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Ultrasound, Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
  • Department of Neurology, Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
  • Department of Hepatic Surgery IV, Shanghai Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.

Zitieren

APA

Jiang, D., Qi, Z., Xu, Z., & Li, Y. (2025). CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition. Oncology Research. https://doi.org/10.32604/or.2024.050125

Vancouver

Jiang D, Qi Z, Xu Z, Li Y. CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition. Oncology Research. 2025. doi:10.32604/or.2024.050125

BibTeX
@article{Jiang2025,
  author = {Jiang, Dong and Qi, Zhi and Xu, Zhiying and Li, Yiran},
  title = {CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2024.050125}
}
Kostenlos starten →